中东和非洲流感疫苗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按疫苗类型（四价疫苗和三价疫苗）、病毒类型（A 型流感病毒和 B 型流感病毒）、技术（基于鸡蛋和基于细胞）、给药途径（注射和鼻喷雾）和目标群体（婴儿、儿童、成人和老年人）
No. of Pages: 135 | Report Code: BMIRE00026955 | Category: Life Sciences
No. of Pages: 135 | Report Code: BMIRE00026955 | Category: Life Sciences
中东和中东地区非洲流感疫苗市场预计将从2022年的3.7435亿美元增长到2028年的5.3385亿美元；预计 2022 年至 2028 年复合年增长率为 6.1%。
政府加大支持力度，促进流感疫苗接种以支持中东地区&预测期内非洲流感疫苗市场
流感疫苗市场的领先企业拥有多个基于专有技术的药物输送和生物管道项目。药物输送领域最先进的候选人群完成了 2 项 I 期研究。该管道还包括大量已完成临床前评估的化合物。管道候选者专注于解锁免疫系统、人类遗传学和尖端技术的科学，以开发创新疫苗。公司正在投资于卓越的科学和技术，以开发和推出针对包括流感在内的传染病的新疫苗和特效药物。正在研发的疫苗和病毒治疗候选药物能够快速、具体地应对中东和非洲地区最紧迫的健康威胁。非洲。因此，强大的流感疫苗候选产品是中东和中东地区的最新趋势。非洲流感疫苗市场。
市场概况
中东和非洲非洲流感疫苗市场分为阿联酋、沙特阿拉伯、南非以及中东其他地区和地区。非洲。 2022年，南非成为该地区最大的流感疫苗市场。中东和非洲流感疫苗市场预计非洲在预测期内的复合年增长率为 6.1%。由于人口基数的增加、流感病例的增加、整个地区研究的不断深入以及医疗设施的增加，流感疫苗市场预计将增长。
中东及中东地区非洲流感疫苗市场收入及预测至 2028 年（百万美元）
中东和非洲非洲流感疫苗市场细分
中东和非洲非洲流感疫苗市场根据疫苗类型、病毒类型、技术、给药途径、目标群体和国家进行细分。
根据疫苗类型，中东及非洲流感疫苗市场分为四价疫苗和三价疫苗。到 2022 年，四价疫苗细分市场将占据更大的市场份额。
根据病毒类型，中东和非洲地区将占据更大的市场份额。非洲流感疫苗市场分为甲型流感病毒和乙型流感病毒。到2022年，甲型流感病毒将占据更大的市场份额。
基于技术、中东和非洲流感疫苗市场分为鸡蛋疫苗和细胞疫苗。到 2022 年，以鸡蛋为基础的细分市场将占据更大的市场份额。
根据给药途径，中东和非洲地区将占据更大的市场份额。非洲流感疫苗市场分为注射剂和鼻喷雾剂。到 2022 年，注射细分市场将占据更大的市场份额。
基于目标群体，中东和非洲地区。非洲流感疫苗市场分为婴儿、儿童、成人和老年人。 2022 年，婴儿细分市场占据最大市场份额。
按国家/地区、中东和非洲地区划分。非洲流感疫苗市场分为沙特阿拉伯、阿联酋、南非以及中东其他地区和地区。非洲。沙特阿拉伯在 2022 年占据市场主导地位。
阿斯利康；葛兰素史克公司；三菱化学集团公司；迈兰公司；赛诺菲； SEQIRUS；和印度血清研究所列兵。有限公司是在中东和中东地区运营的领先公司。非洲流感疫苗市场。
Strategic insights for Middle East & Africa Influenza Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 374.35 Million |
| Market Size by 2028 | US$ 533.85 Million |
| Global CAGR (2022 - 2028) | 6.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 疫苗类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Influenza Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Influenza Vaccines Market is valued at US$ 374.35 Million in 2022, it is projected to reach US$ 533.85 Million by 2028.
As per our report Middle East & Africa Influenza Vaccines Market, the market size is valued at US$ 374.35 Million in 2022, projecting it to reach US$ 533.85 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The Middle East & Africa Influenza Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Influenza Vaccines Market report:
The Middle East & Africa Influenza Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Influenza Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Influenza Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Influenza Vaccines Market
